{"version":"1.0","type":"link","title":"Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.","author_name":"Zhu HD 외","author_url":"https://prs-insight.online/author/Zhu%20HD","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/106344","thumbnail_width":1200,"thumbnail_height":630}